The Enterprise Value as of December 2025 (TTM) for ARS Pharmaceuticals, Inc. (SPRY) is 920.95M

According to ARS Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 920.95M. This represents a change of -22.90% compared to the average of 1.19B of the last 4 quarters.

ARS Pharmaceuticals, Inc. (SPRY) Historical Enterprise Value (quarterly & annually)

How has SPRY Enterprise Value performed in the past?

The mean historical Enterprise Value of ARS Pharmaceuticals, Inc. over the last ten years is 705.02M. The current 920.95M Enterprise Value has changed 12.96% with respect to the historical average. Over the past ten years (40 quarters), SPRY's Enterprise Value was at its highest in in the June 2025 quarter at 1.67B. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

ARS Pharmaceuticals, Inc. (SPRY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ARS Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ARS Pharmaceuticals, Inc. (SPRY) Average Enterprise Value

How has SPRY Enterprise Value performed in the past?

The current Enterprise Value of ARS Pharmaceuticals, Inc. (SPRY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ARS Pharmaceuticals, Inc. (SPRY) Enterprise Value vs. Peers

How is SPRY’s Enterprise Value compared to its peers?

ARS Pharmaceuticals, Inc.’s Enterprise Value is greater than GH Research PLC (698.93M), greater than Nanobiotix S.A. (890.26M), greater than Arbutus Biopharma Corporation (826.05M), greater than LENZ Therapeutics, Inc. (742.15M), less than Savara Inc. (1.31B), greater than Rezolute, Inc. (891.81M), less than Kura Oncology, Inc. (961.31M), less than ProKidney Corp. (1.56B), less than Palvella Therapeutics, Inc. (1.05B), less than Tyra Biosciences, Inc. (1.09B),

Build a custom stock screener for ARS Pharmaceuticals, Inc. (SPRY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ARS Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ARS Pharmaceuticals, Inc. (SPRY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ARS Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.